About
Remi-Martin Laberge, PhD, is a biotech operator-scientist focused on pathogenic cell elimination, senolytics, and chronic disease biology. He is founder and CTO of Arda Therapeutics, where he helps build targeted cell-depletion therapies for chronic diseases. Previously he was Head of Cellular Biology at Unity Biotechnology and VP of Scientific Operations at IRICoR, and he has published extensively in aging and translational biology.
Areas of interest
longevitybiotechaging biologysenolyticspathogenic cell eliminationsingle-cell biologydrug discoveryfibrosischronic diseasetranslational medicine